Home > Organization > Divisions and Independent Research Units > Division of Rare Cancer > member > Kazutaka Kikuta

Kazutaka Kikuta

Name	Kazutaka Kikuta
Specialty	Rare Cancer Researcn、Musculoskeletal oncological research, Orthopaedic Surgery, Proteomics

Academic degree	MD (2002), PhD (2010) Thesis: Nucleophosmin as a candidate prognostic biomarker of Ewing sarcoma revealed by Proteomics Clinical Cancer Research, 15:2885-2894, 2009
Education	Keio University School of Medicine (2002), Medical Science, Graduate School of Meicine, Keio University School of Medicine (2010)
Social activity	Member, The Japanese Orthopaedic Association Member, Japanese Cancer Association Member, Japanese Musculoskeletal Oncology Group Member, Japanese Proteomics Society Member, Japanese Electrophoresis Society Member, Societe Franco-Japonaise d’ Orthopedie
Comments on research	Malignant bone and soft tissue tumor is one of rare cancers, unfortunately it is a field that is delayed in diagnosis and development of therapy for patients. For this reason, we aim to provide better medical care to patients by utilizing proteome analysis as a tumor surgeon, aiming at development of biomarkers useful for diagnostic treatment of malignant bone  and soft tissue tumors using proteome analysis.
Current research interests	I am conducting proteome analysis aiming at development of biomarkers useful for diagnostic treatment of malignant bone and soft tissue tumor. We are mainly engaged in research on invasive soft tissue sarcoma with particularly strong invasive character.